aluminum sulfate has been researched along with Infections, Coronavirus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bottazzi, ME; Corry, DB; Hotez, PJ; Strych, U | 1 |
| Cao, F; Dai, L; Gao, XD; Ma, G; Peng, S; Xia, Y; Yan, J | 1 |
| Chen, K; Gao, F; Gao, W; He, W; Pan, W; Song, D; Wang, C; Wang, L; Zhao, C; Zhao, K | 1 |
3 other study(ies) available for aluminum sulfate and Infections, Coronavirus
| Article | Year |
|---|---|
COVID-19 vaccines: neutralizing antibodies and the alum advantage.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Coronavirus Infections; COVID-19 Vaccines; Humans; Macaca mulatta; Mice; Viral Vaccines | 2020 |
Particulate Alum via Pickering Emulsion for an Enhanced COVID-19 Vaccine Adjuvant.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens, Viral; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Emulsions; HEK293 Cells; Humans; Interferon-gamma; Mice, Inbred BALB C; Pandemics; Pneumonia, Viral; Spike Glycoprotein, Coronavirus; T-Lymphocytes; Viral Vaccines | 2020 |
Comparative evaluation of two hemagglutinating encephalomyelitis coronavirus vaccine candidates in mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Coronavirus; Coronavirus Infections; Disease Models, Animal; Female; Immunoglobulin G; Interferon-gamma; Interleukin-2; Interleukin-4; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Vaccines, DNA; Vaccines, Inactivated; Vaccines, Synthetic; Viral Vaccines | 2012 |